Neurophysiological studies in GM1, gangliosidosis
- PMID: 6819251
- DOI: 10.1007/BF02043310
Neurophysiological studies in GM1, gangliosidosis
Abstract
Neurophysiological studies (EEG, ERG, VEP) have been carried out on 8 children with proven GM1 gangliosidosis (3 of Type I and 5 of Type II). All the EEGs were abnormal showing an increasing amount of irregular slow activity as the disease progressed. Around 2 to 3 years of age, Type II patients often showed a fluctuating 4-5 c/s rhythmic activity especially prominent in the temporal regions. Paroxysmal activity was not a conspicuous feature in any of the patients. The ERG was normal in all cases but the VEP was variably altered. The EEG/ERG/VEP findings in GM1 gangliosidosis differ from those seen in most other neurometabolic disorders of childhood.
Similar articles
-
Neurophysiological investigations in GM1 and GM2 gangliosidoses.Neuropediatrics. 1984 Sep;15 Suppl:74-84. doi: 10.1055/s-2008-1052386. Neuropediatrics. 1984. PMID: 6100798
-
Adrenoleucodystrophy: neurophysiological aspects.J Neurol Neurosurg Psychiatry. 1981 Sep;44(9):781-5. doi: 10.1136/jnnp.44.9.781. J Neurol Neurosurg Psychiatry. 1981. PMID: 7310417 Free PMC article.
-
"Mitochondrial myopathy" or mitochondrial disease? EEG, ERG, VEP studies in 13 children.J Neurol Neurosurg Psychiatry. 1982 Jul;45(7):627-32. doi: 10.1136/jnnp.45.7.627. J Neurol Neurosurg Psychiatry. 1982. PMID: 7119830 Free PMC article.
-
Neuropathology of late onset gangliosidoses. A review.Dev Neurosci. 1991;13(4-5):205-10. doi: 10.1159/000112161. Dev Neurosci. 1991. PMID: 1817025 Review.
-
[Lysosomal beta-galactosidase properties and the molecular genetics of GM1 gangliosidosis].Vopr Med Khim. 1979 Nov-Dec;25(6):709-15. Vopr Med Khim. 1979. PMID: 117628 Review. Russian.
Cited by
-
A pentasaccharide for monitoring pharmacodynamic response to gene therapy in GM1 gangliosidosis.EBioMedicine. 2023 Jun;92:104627. doi: 10.1016/j.ebiom.2023.104627. Epub 2023 May 31. EBioMedicine. 2023. PMID: 37267847 Free PMC article.
-
Novel Biomarkers of Human GM1 Gangliosidosis Reflect the Clinical Efficacy of Gene Therapy in a Feline Model.Mol Ther. 2017 Apr 5;25(4):892-903. doi: 10.1016/j.ymthe.2017.01.009. Epub 2017 Feb 22. Mol Ther. 2017. PMID: 28236574 Free PMC article.